Clinion eConsent - 2026 Pricing, Features, Reviews & Alternatives

Clinion eConsent digitizes and streamlines the informed consent process for clinical trials. The platform replaces traditional paper workflows with multimedia-enhanced digital forms accessible on personal or site-provided devices. It addresses operational challenges in slow enrolment, consent version control and participant comprehension by providing patient-centric workflows, real-time tracking and seamless integration with clinical trial management systems.

The platform offers three deployment models to accommodate study requirements. Site eConsent enables participants to review and sign forms on site-provided tablet devices. Remote eConsent allows review and digital signature on personal devices from any location and supports teleconsultation functionality to connect principal investigators with participants during consent review. The third model integrates electronic patient reported outcomes workflows into the consent process.

Interactive decision-making is supported through embedded questions, multimedia content such as videos and visual aids and live support to enhance comprehension. Automated reconsenting workflows trigger when protocol amendments occur and notify participants while enabling investigators to monitor reconsent status in real time. Version control functionality tracks all consent form iterations with time-stamped signatures and audit-ready logs that document every action.

The platform provides multilingual support and cross-platform compatibility across iOS, Android and tablet operating systems. Upon consent completion, the system delivers digitally signed forms to participants for secure record keeping and enrolls subjects into the electronic data capture system at the same time. Study teams gain dashboard visibility of subject enrollment status and consent metrics without manual intervention or paperwork delays. Clinion eConsent integrates with the Clinion electronic data capture platform and other clinical trial systems to centralize data access and provide real-time consent status updates. Built to comply with United States Food and Drug Administration regulations, Good Clinical Practice guidelines, twenty one CFR part eleven, the Health Insurance Portability and Accountability Act and the General Data Protection Regulation, the platform employs end-to-end encryption, role-based access controls and detailed access logs to safeguard participant data. The audit trail records comprehensive version histories and time stamps all user interactions to support regulatory inspections and sponsorship requirements.